Literature DB >> 1688835

Crystalloid versus colloid fluid therapy after cardiac surgery.

S J Ley1, K Miller, P Skov, P Preisig.   

Abstract

Differences in hemodynamic stability and fluid requirements were examined in patients randomly assigned to receive either normal saline crystalloid solution (N = 10) or hetastarch colloid solution (N = 11) after coronary artery bypass or valve operation. Both solutions were administered in the same manner for 8 hours after surgery, with hourly assessment of hemodynamic parameters and intake/output data. Infusion rates and 8-hour intake were higher for the group receiving normal saline solution (p less than 0.001), as was postoperative weight gain (p less than 0.01), although urine and chest tube outputs did not differ. Despite lower filling pressures, subjects receiving hetastarch exhibited higher systolic blood pressures and cardiac outputs (p less than 0.05). Hematocrits on postoperative day 1 were lower in the group given hetastarch (p less than 0.001), suggesting prolonged intravascular expansion. The subjects given hetastarch also required significantly less time in the intensive care unit (p less than 0.001). Thus, cardiac surgical patients receiving colloids exhibited reduced fluid requirements, superior hemodynamic performance, and shortened intensive care stay when compared with those given crystalloid resuscitation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688835

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  5 in total

1.  Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery.

Authors:  Joanne Verheij; Arthur van Lingen; Albertus Beishuizen; Herman M T Christiaans; Jan R de Jong; Armand R J Girbes; Willem Wisselink; Jan A Rauwerda; Marinus A J M Huybregts; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2006-05-23       Impact factor: 17.440

Review 2.  Hydroxyethyl starch for cardiovascular surgery: a systematic review of randomized controlled trials.

Authors:  Xue-Yin Shi; Zui Zou; Xing-Ying He; Hai-Tao Xu; Hong-Bin Yuan; Hu Liu
Journal:  Eur J Clin Pharmacol       Date:  2011-03-02       Impact factor: 2.953

3.  Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.

Authors:  Bin He; Bo Xu; Xiaoxing Xu; Lixia Li; Rongrong Ren; Zhiyu Chen; Jian Xiao; Yingwei Wang; Bin Xu
Journal:  Crit Care       Date:  2015-03-19       Impact factor: 9.097

4.  The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis.

Authors:  Matthias Jacob; Jean-Luc Fellahi; Daniel Chappell; Andrea Kurz
Journal:  Crit Care       Date:  2014-12-04       Impact factor: 9.097

5.  Colloids versus crystalloids for fluid resuscitation in critically ill people.

Authors:  Sharon R Lewis; Michael W Pritchard; David Jw Evans; Andrew R Butler; Phil Alderson; Andrew F Smith; Ian Roberts
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.